title: Tolerance of full dose menogaril (NSC 269148) in patients with abnormal hepatic and renal function.
authors: Division of Development Therapeutics, University of Maryland Cancer Center, Baltimore.
authors: B A
authors: BA
authors: Conley
authors: M J
authors: MJ
authors: Egorin
authors: V
authors: V
authors: Sinibaldi
authors: D A
authors: DA
authors: Van Echo
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism; D004334:Drug Administration Schedule; D015507:Drugs, Investigational / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000378:metabolism*; D008107:Liver Diseases / Q000378:metabolism*; D008297:Male; D017290:Menogaril; D008875:Middle Aged; D009621:Nogalamycin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism; D011446:Prospective Studies
chemical_list: D000970:Antineoplastic Agents; D015507:Drugs, Investigational; D017290:Menogaril; D009621:Nogalamycin